The HCP Hub is a portal with information intended only for qualified and practicing healthcare practitioners.
If your country of origin is Austria or Germany, please login with your DocCheck credentials.
Login for HCPs
Please select your country of origin.
Please answer the following statement
I am a qualified healthcare practitioner and I am qualified to view information about the treatment and medication of pulmonary arterial hypertension.
Welcome to PH Network HCP Hub
Trouble accessing the patient portal
If you’ve lost your password or need help accessing the HCP HUB, please contact support[at]aop-global.com
Or speak with your care team for help.
Treprostinil is indicated for the treatment of idiopathic or heritable pulmonary arterial hypertension (PAH) to improve exercise tolerance and symptoms of the disease in patients classified as New York Heart Association (NYHA) functional class III.
Prescribing information for Treprostinil can be found here.